| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.91B | $1.77B | $1.44B |
| YoY Revenue Growth % | +8.3% | +22.7% | — |
| Gross Profit | $569.5M | $534.2M | — |
| Gross Margin % | 29.8% | 30.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $44.1M | $25.9M | -$63.7M |
| Operating Margin % | 2.3% | 1.5% | -4.4% |
| Net Income (GAAP) | $42.3M | -$3.8M | -$82.0M |
| EBITDA (Normalized) | $80.0M | $54.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $208.4M | $184.3M | $84.4M |
| Capital Expenditures (CapEx) | $44.9M | $35.2M | — |
| Free Cash Flow (FCF) | $163.4M | $149.2M | $84.4M |
| FCF Margin % | 8.5% | 8.4% | 5.9% |
| Return on Invested Capital (ROIC %) | 3.9% | 2.2% | — |
| Cash & Short-Term Equivalents | $120.9M | $226.6M | — |
| Total Debt (Short + Long Term) | $102.3M | $116.5M | — |
| Total Stockholders' Equity | $907.2M | $1.05B | — |